Saioa Rubio Iturria

Statistics

Publications

Citations

308

H-Index

Active since

2015

Affiliations

Complejo Hospitalario de Navarra(Current)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Hospital Clínico Universitario de Valencia

Instituto de Investigación Marqués de Valdecilla

Hospital Universitario Infanta Sofía

Saioa Rubio Iturria is an author at Complejo Hospitalario de Navarra specializing in inflammatory bowel disease therapy, inflammatory bowel disease, and pharmacotherapy.

ORCID

Publications per year

2015–2023

Publications

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry

María Chaparro, A Garre, Francisco Mesonero et al. · Journal of Crohn s and Colitis · 2020 · 102 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

María Chaparro, A Garre, Marisa Iborra et al. · Journal of Crohn s and Colitis · 2021 · 81 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study

María Chaparro, Iria Bastón‐Rey, E Fernández-Salgado et al. · Inflammatory Bowel Diseases · 2022 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis

Carlos Taxonera, Marisa Iborra, Marta Maia Boscá-Watts et al. · Current Medical Research and Opinion · 2019 · 18 citations

Medicine, Immunology, Pharmacotherapy +17

Tofacitinib, useful option for the treatment of pyoderma gangrenosum in an ulcerative colitis patient

Pablo Salmón Olavarría, Saioa Rubio Iturria, Óscar Nantes · Revista Española de Enfermedades Digestivas · 2021 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

1–5 of 8